KAZIA THERAPEUTICS LTD
KZIA · XNASCIK 1075880fmd_0PC95CVW80NR33ZK725476844XManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2015 to Dec 31, 2025, 15 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | – | – | 15 | 0 | 0 | 2 | 0 |
| Research and development | 10 | 11 | 10 | 6 | 9 | 15 | 20 | 16 | 17 | 7 |
| Selling, general and administrative | 6 | 9 | 6 | 4 | 4 | 7 | 5 | 9 | 14 | 9 |
| Interest expense | 0 | 1 | 0 | – | – | – | – | – | – | – |
| Income before taxes | (12) | (11) | (6) | (11) | (13) | (9) | (25) | (21) | (27) | (22) |
| Income tax expense | – | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (2) |
| Net income from continuing operations | – | (11) | (6) | (10) | (12) | (8) | (25) | (20) | (27) | (21) |
| Net income | (12) | (11) | (6) | (10) | (12) | (8) | (25) | (20) | (27) | (21) |